US Patent Issued to HMNC Holding on June 9 for "Method of treatment using genetic predictors of a response to treatment with CRHR1 antagonists" (German Inventor)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,947, issued on June 9, was assigned to HMNC Holding GmbH (Munich).

"Method of treatment using genetic predictors of a response to treatment with CRHR1 antagonists" was invented by Florian Holsboer (Munich).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of treating a condition which is treatable with SSR-125543 or a pharmaceutically acceptable salt thereof in a subject in need thereof are provided. The methods of treatment include predicting a treatment response of a subject to a treatment with SSR-125543 and/or detecting a polymorphism genotype associated with a treatment response of a subject to treatment with SSR-125543. Sets of at least one...